CRISPR Therapeutics AG (CRSP)
40.72
+0.34
(+0.83%)
USD |
NASDAQ |
Dec 20, 16:00
40.87
+0.15
(+0.37%)
After-Hours: 20:00
CRISPR Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 2.772B |
| Lonza Group Ltd | -- |
| AC Immune SA | 29.47M |
| Addex Therapeutics Ltd | 0.0623M |
| NLS Pharmaceutics Ltd | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -85.94M |
| Total Expenses (Quarterly) | 110.13M |
| EPS Diluted (Quarterly) | -1.01 |
| Enterprise Value | 1.540B |
| Earnings Yield | -6.88% |
| Normalized Earnings Yield | -4.740 |